20 annual accounts with figures on one time axis, 34 filings since 1993
peak of €682,075 in 2024
€453,164▲ 55.1%
lowest -€33,885 in 2010
€194,821▲ 42.7%
peak of €1.7m in 2025
€1.3m▼ 26.4%
€196,830▲ 119%
peak of 0.8 FTE in 2017
-not published
Board1 name since 2022
1 directorName after signing inVisible after signing in
Documentsfilings and deeds
28-09-20262 days before the deadline
2026micro format
Gross margin from €292,122 to €453,164Result from €136,478 to €194,821Dividend €643,078Equity from €1.7m to €1.3mDebts from €89,854 to €196,830Investments €191,229
More equity than 93% of companies in human health. The sector median is €192,375, over 582 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 31,388 companies had the same profile as Dr. L. BORMS has now. Each dot stands for 79 companies, two years later.
93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
Micro
20 years or older
solvency 30% or more
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.4%
0.5%
3
0.6%
0.6%
4
0.7%
0.8%
5
0.9%
1.0%
6
1.4%
1.6%
7
1.7%
1.8%
8
1.9%
2.0%
9
3.1%
3.3%
10
5.9%
6.4%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,388 companies, not a prediction for Dr. L. BORMS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0446601361
Registered office moved within Dendermonde
The registered office moved from Lambroeckstraat 37, 9200 Dendermonde to Lambroeckstraat 76 bus 7, 9200 Dendermonde · Name after signing inVisible after signing in resigns as manager · Name hiddenVisible after signing in reappointed as statutory director · General meeting of 19-12-2023 · Gazette deed
Capital decrease of €402,654 to €37,200
The capital fell from €439,854 to €37,200 · General meeting of 06-02-2018 · Gazette deed
Capital increase of €402,654 to €439,854
The capital rose from €37,200 to €439,854, with 302 new shares · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as Dr. L. BORMS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €1.3m and €1.7m, founded between 1987 and 1996.
The company number of Dr. L. BORMS is 0446.601.361. The VAT number is the same number with BE in front: BE 0446.601.361.
Where is Dr. L. BORMS based?
The registered office is at Lambroeckstraat 76, 9200 Dendermonde.Company details
What does Dr. L. BORMS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. L. BORMS?
Dr. L. BORMS is a private limited company (BV).
When was Dr. L. BORMS founded?
Dr. L. BORMS was founded on 19-02-1992.
Is Dr. L. BORMS still active?
Yes, Dr. L. BORMS is an active enterprise in the KBO register.
How many employees does Dr. L. BORMS have?
Dr. L. BORMS had an average of 1 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
Which joint committee does Dr. L. BORMS fall under?
In its 28-02-2026 annual accounts, Dr. L. BORMS states joint committee 330.04 (Health institutions and services).
What is the turnover of Dr. L. BORMS?
The turnover in financial year 2026 is about €690,000. This figure is estimated from the gross margin of €453,164 and 38 comparable companies (NACE 862). It probably lies between €600,000 and €870,000.
Is Dr. L. BORMS profitable?
In financial year 2026, Dr. L. BORMS made a profit of €194,821.
Where can I find the annual accounts of Dr. L. BORMS?
Dr. L. BORMS filed 34 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of Dr. L. BORMS due?
Dr. L. BORMS must file the annual accounts for financial year 2027 by 30-09-2027.Timeline